For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy.

A North Carolina woman has filed a lawsuit in New Jersey federal court, claiming that her use of the diabetes medication Ozempic led to permanent vision loss. Elizabeth Pennell alleges that Novo ...

Blockbuster weight loss meds like Ozempic and Wegovy are now linked to a rare eye disease that can lead to blindness.

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

An update on the execution of the two Phase 3 DIAMOND trials of OCS-01 eye drops in diabetic macular edema (DME), with enrollment for both studies completed (>800 patients) and topline data ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Researchers from the University of Bern analyzed over 300,000 FDA reports and found semaglutide use was linked to a higher ...

Patients on amiodarone usually have risk factors for vascular disease, which is the primary cause of non-arteritic anterior ischemic optic neuropathy (NAION), leading to frequent misdiagnosis of AAON ...

Taiwan: A recent cohort study published in JAMA Ophthalmology suggests that patients with diabetes who use semaglutide may face an increased risk of developing nonarteritic anterior ischemic optic ...